Brinton Pharmaceuticals informed that it has more than tripled up the production of Faviton (Favipiravir 400) tablets. Favipiravir is used as an oral antiviral therapy for mild to moderate cases of COVID-19.
Brinton Pharmaceuticals has received approval from Drugs Controller General of India (DCGI) for the launch of Favipiravir 400mg under the brand name Faviton.